|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Stock-based compensation, net of capitalized cost of $2,605, $2,339 and $2,344, respectively | |||||
| Change in fair value of warrant liabilities | |||||
| Change in fair value of contingent consideration | |||||
| Debt extinguishment loss | |||||
| Amortization of debt discount and issuance costs | |||||
| Impairment of capitalized internal-use software | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued and other liabilities | |||||
| Deferred revenue | |||||
| Deferred hosting costs | |||||
| Deferred rent | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Capitalized internal-use software | |||||
| Maturities of available-for-sale securities | |||||
| Sales of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Business acquisition, net of cash acquired | |||||
| Purchases of licensed imagery intangible assets | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Proceeds from the exercise of common stock options | |||||
| Payments for withholding taxes related to the net share settlement of equity awards | |||||
| Proceeds from the early exercise of common stock options | |||||
| Principal payment of debt | |||||
| Proceeds from employee stock purchase program | |||||
| Payments of contingent consideration for business acquisitions | |||||
| Payment of indemnification holdback for business acquisition | |||||
| Proceeds from issuance of convertible notes, net of discount | |||||
| Payment of debt issuance costs | |||||
| Proceeds from the exercise of warrants | |||||
| Purchase of capped call transactions | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalent | |||||
| Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | |||||
| Cash paid for interest | |||||
| Net cash paid (received) for income tax | |||||
| Supplemental disclosures of noncash investing and financing activities | |||||
| Contingent consideration for business acquisition | |||||
| Issuance of Class A common stock for business acquisition | |||||
| Common Class A | |||||
| Total issuance of Class A common stock for business acquisition | |||||
| Reclassification of convertible preferred stock warrant liabilities converted to Class A common stock warrants | |||||
| Transfers from property and equipment, net to inventories, net | |||||
| Accrued purchase of property and equipment | |||||
Loading...